A promising new regimen for the treatment of advanced extranodal NK/T cell lymphoma

被引：12
作者：
Farid, Mohamad [1 ]
Yau, Ying Wei [1 ]
Tay, Kevin [1 ]
Quek, Richard [1 ]
Tao, Miriam [1 ]
Koo, Ghee Chong [1 ]
Loong, Susan [1 ]
Lim, Soon Thye [1 ]
机构：
[1] Natl Canc Ctr Singapore, Dept Med Oncol, Singapore 169610, Singapore
来源：
ACTA ONCOLOGICA | 2011年 / 50卷 / 04期
关键词：
GEMCITABINE; OXALIPLATIN;
D O I：
10.3109/0284186X.2010.516272
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：589 / 590
页数：2
相关论文
共 11 条
  • [1] P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833
    Egashira, M
    Kawamata, N
    Sugimoto, K
    Kaneko, T
    Oshimi, K
    [J]. BLOOD, 1999, 93 (02) : 599 - 606
  • [2] Supraadditive effect of 2′,2′-difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines
    Faivre, S
    Raymond, E
    Woyarowski, JM
    Cvitkovic, E
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 44 (02) : 117 - 123
  • [3] Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma
    Fosså, A
    Santoro, A
    Hiddemann, W
    Truemper, L
    Niederle, N
    Buksmaui, S
    Bonadonna, G
    Seeber, S
    Nowrousian, MR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) : 3786 - 3792
  • [4] Hagemeister FB, 2001, EUR J HAEMATOL, V66, P1
  • [5] KOO GC, 2009, BIT LIF SCI 2 ANN WO
  • [6] Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis
    Lim, Soon Thye
    Hee, Siew Wan
    Quek, Richard
    Lim, Lay Cheng
    Yap, Swee Peng
    Loong, Er-Li
    Sng, Ivy
    Tan, Leonard Hwan-Cheong
    Ang, Mei-Kim
    Ngeow, Joanne
    Tham, Chee-Kian
    Ngo, Lynette
    Tan, Min Han
    Tao, Miriam
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 80 (01) : 55 - 60
  • [7] An Epstein-Barr virus positive natural killer lymphoma xenograft derived for drug testing
    Loong, Susan Li Er
    Hwang, Jacqueline Siok Gek
    Lim, Soon-Thye
    Yap, Swee Peng
    Tao, Miriam
    Chong, Tsung-Wen
    Tan, Leonard Hwan Cheong
    Huynh, Hung
    [J]. LEUKEMIA & LYMPHOMA, 2008, 49 (06) : 1161 - 1167
  • [8] Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma
    Oki, Y
    McLaughlin, P
    Pro, B
    Hagemeister, FB
    Bleyer, A
    Loyer, E
    Younes, A
    [J]. CANCER, 2005, 104 (04) : 781 - 787
  • [9] Gemcitabine for relapsed or resistant lymphoma
    Savage, DG
    Rule, SAJ
    Tighe, M
    Garrett, TJ
    Oster, MW
    Lee, RT
    Ruiz, J
    Heitjan, D
    Keohan, ML
    Flamm, M
    Johnson, SA
    [J]. ANNALS OF ONCOLOGY, 2000, 11 (05) : 595 - 597
  • [10] Storniolo A M, 1997, Semin Oncol, V24, pS7
12